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ABSTRACT: The maintenance of bacterial cell shape and integrity is largely attributed to peptidoglycan, a highly cross-
linked biopolymer. The transpeptidases that perform this cross-linking are important targets for antibiotics. Despite this
biomedical importance to date no structure of a protein in complex with an intact bacterial peptidoglycan has been re-
solved, primarily due to the large size and flexibility of peptidoglycan sacculi. Here we use solid-state NMR spec-
troscopy to derive for the first time an atomic model of an L,D-transpeptidase from Bacillussubtilis bound to its natural
substrate, the intact B. subtilis peptidoglycan. Importantly, the model obtained from protein chemical shift perturbation
data shows that both domains – the catalytic domain as well as the proposed peptidoglycan recognition domain – are
important for the interaction and reveals a novel binding motif that involves residues outside of the classical enzymatic
pocket. Experiments on mutants and truncated protein constructs independently confirm the binding site and the impli-
cation of both domains. Through measurements of dipolar-coupling derived order parameters of bond motion we show
that protein binding reduces the flexibility of peptidoglycan. This first report of an atomic model of a protein-peptidogly-
can complex paves the way for the design of new antibiotic drugs targeting L,D-transpeptidases. The strategy devel-
oped here can be extended to the study of a large variety of enzymes involved in peptidoglycan morphogenesis.
Introduction
For over 70 years, peptidoglycan (PG) has played a
pivotal role in the development of antibacterial chemo-
therapy.1 In the quest for new drugs, the biosynthetic
pathway of this ubiquitous cell wall polymer has been de-
ciphered and essential peptidoglycan-synthesizing en-
zymes have been identified as putative antibacterial tar-
gets. Peptidoglycan precursors are synthesized in the
cytoplasm, exported and assembled in the extracytoplas-
mic space by Penicillin-Binding Proteins (PBPs) that are
the essential targets of β-lactam and glycopeptide antibi-
otics.2 In ampicillin–resistant mutants of Enterococcus fae-
cium3 and in wild-type Mycobacterium tuberculosis4 pepti-
doglycan cross-linking is not catalyzed by PBPs but by
L,D-transpeptidases (Ldts). The Ldt from Bacillus subtilis
(LdtBs) was shown to catalyze this reaction in vitro.5 LdtBs
consists of an N-terminal Lysin-Motif domain (LysM,
residues 1 to 54) linked to the C-terminal catalytic do-
main (residues 55 to 169). The two domains have close
contacts, remaining in a fixed relative orientation, as
shown by NMR and X-ray studies.6,7 The catalytic do-
mains of LdtBs and Ldts from E. faecium (Ldtfm)8 and M. tu-
berculosis (LdtMt2, LdtMt1)9,10,11 display similar folds but the
proteins have different domain compositions. The active
site of Ldts contains a catalytic cysteine, which forms a
covalent adduct with the tetrapeptide stem used as the
acyl donor in the cross-linking reaction. Then, the Cys-
bound tripeptide stem reacts with an adjacent peptide
stem acting as an acyl acceptor, resulting in cross-linking
and release of Ldt. The active-site Cys residue is also
acylated by β-lactams of the carbapenem class resulting
in irreversible enzyme inactivation.3
LysM domains are widely spread in both prokaryotes
and eukaryotes12 and are known to bind non-covalently
to peptidoglycan and chitin by interacting with N-acetyl-
glucosamine residues.13 In bacteria, various enzymes
involved in peptidoglycan morphogenesis during growth
and cell division are known to use one or several modu-
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lar LysM domains to bind to peptidoglycan.14,15 However,
little is known on the role of LysM in determining the lo-
calization of the proteins in physiologically relevant sites
within the peptidoglycan layer and how recognition of
specific peptidoglycan patterns by LysM domains might
modulate protein function. Addressing these questions
ideally requires the study of intact peptidoglycan.
Atomic-resolution studies of proteins interacting with
an intact bacterial cell wall are challenging. The peptido-
glycan sacculus is a gigadalton-large, dynamic and mi-
croscopically heterogeneous structure, which hampers
structural investigations by X-ray crystallography as well
as solution-state NMR. Electron cryotomography and
atomic-force microscopy offer insight into the overall
structure and architecture of peptidoglycan,16–18 but the
resolution presently obtained with these techniques does
not allow resolving structural details of protein/peptido-
glycan complexes at atomic resolution. The considerable
flexibility of peptidoglycan19 represents a further chal-
lenge for EM and AFM. For all the above reasons, there
are currently no atomic-resolution data available with re-
spect to the structure of proteins in interaction with intact
cell wall peptidoglycan, or giving insight into the dynam-
ics of such complexes. Fragments of peptidoglycan may
be used to reconstitute complexes, which may crystallize
or be amenable to solution-state NMR.20 However, these
fragments may only partially reproduce the structure and
affinities of the intact cell wall and are thus insufficient in
a larger picture. 
Solid-state NMR (ssNMR) can circumvent these limita-
tions, because it provides atomic resolution, indepen-
dently from the size or crystallinity of the molecular sys-
tem studied. SsNMR has been applied in a few cases to
entire organelles, membranes or whole cells.21,22 In the
case of peptidoglycan, the repetition of of disaccharide-
peptide building blocks in the polymer (see Figure 1A)
and its intrinsic flexibility lead to relatively simple and
well-resolved spectra. In the context of bacterial cell wall,
ssNMR has proven to be a useful tool to obtain informa-
tion about chemical modifications, local structure and dy-
namics of peptidoglycan, as well as interactions of the
polymer with antibiotics and ions.19,23,24 Low-resolution
models of the architecture of peptidoglycan architecture
have been proposed, for peptidoglycan from Staphylococ-
cus aureus a nd Enterococcus faecium based on NMR
data,25,26 but not for peptidoglycan from B. subtilis. Here
we show for the first time that it also provides information
on the structure and dynamics of protein/PG complexes,
through the investigation of the interaction of the L,D-
transpeptidase LdtBs with its physiological substrate, the
peptidoglycan from B. subtilis.
Experimental Section
Sample preparation
Samples of B. subtilis peptidoglycan were prepared as
described previously,24 and outlined in the Supporting In-
formation. Briefly, B. subtilis strain 168 cells were grown
in rich medium, and harvested at an OD600 of ~0.7. The
cell membranes and cytoplasm were removed by treat-
ment with SDS, DNAse and RNAse. The samples were
kept in aqueous suspension during the entire treatment,
including the subsequent NMR measurements, and are
thus well hydrated, retaining a high degree of flexibility.19
Proteins were produced by bacterial over-expression us-
ing standard protocols (see Supporting Information). Af-
ter extensively washing the peptidoglycan with the pro-
tein buffer (50 mM HEPES, pH 7.2) by repeated resus-
pension and centrifugation cycles, protein-peptidoglycan
samples were obtained by incubating peptidoglycan sus-
pensions with LdtBs solutions (0.3-1 mM protein concen-
tration). For solid-state NMR, this highly hydrated sus-
pension was pelleted into either 1.3 mm, 1.6 mm or 3.2
mm ssNMR MAS rotors using a centrifugal device. A full
3.2 mm rotor, with a total sample mass of 25 mg wet pro-
tein/peptidoglycan pellet, typically contained about 3 mg
of protein. Different samples were used in this study,
with proteins either unlabeled, U-[13C15N]- or U-
[2H13C15N]-labeled. Peptidoglycan was either unlabeled
(for protein-detected experiments) or U-13C15N-labeled.
NMR spectroscopy and structure calculation 
All NMR experiments reported in the main text were
carried out on an Agilent 600 MHz VNMRS spectrome-
ter, operating either with a MAS solid-state equipment
(1.6 mm probe for 1H-detected experiments or 3.2 mm
triple-resonance HXY probe for 13C-detected experi-
ments), or a room-temperature solution-state probe. Ad-
ditional 13C-detected experiments reported in the Sup-
porting Information were recorded on a 1000 MHz
Bruker spectrometer with a 3.2 mm HCN probe. All ex-
periments were performed at a sample temperature of
298 K, and temperature calibration in solids was per-
formed using external temperature calibration with KBr,25
which was found to be in very good agreement with tem-
perature measurement of the bulk water line relative to
the DSS signal in wet protein samples. Solid-state NMR
experiments used MAS frequencies of either 7.716 kHz
(for the R1817 experiment on peptidoglycan), 12 or 12.5
kHz (for 13C-detected experiments on LdtBs) or 39 kHz
(for 1H-detected experiments on LdtBs), or 54 kHz (for H-
N REDOR experiments shown in the Supporting Infor-
mation). Details on experiments and data collection are
reported in the Supporting Information. Spectra were
processed with nmrPipe26 and analyzed with CcpNmr27
or in-house written python scripts based on NMRglue.30
Dipolar-coupling data were fitted with the use of numeri-
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cal spin simulations implemented in SIMPSON31 (for
R1817) or GAMMA32 (for REDOR) and in-house written
python programs. Dipolar order parameters are given
relative to rigid-limit values of the dipolar coupling, D rigid,
based on 1.12 Å and 1.02 Å bond lengths for 1H-13C and
1H-15N, respectively, i.e. S = Dmeasured/Drigid.
Residue-specific resonance assignmenf of LdtBs in so-
lution (without peptidoglycan) was performed by triple-
resonance experiments, as reported before.6 The 3D
hCANH spectrum of LdtBs bound to PG was obtained us-
ing a proton-detected experiment based on cross-polar-
ization steps,33 as outlined in the Supporting Information.
The docking of the protein on the peptidoglycan was
performed using HADDOCK34 /CNS35 protocols. As start-
ing structures of the two binding partners we used the
solution-NMR structure of LdtBs and a set of ten struc-
tures of a hexameric muropeptide fragment, as de-
scribed in the Supporting Information. The docking proto-
col used ambiguous restraints to the protein residues
that showed significant chemical-shift perturbation in H-
N-CA experiments (larger than twice the standard devia-
tion over the whole sequence). For the muropeptide,
where no unambiguously identified binding sites are
available, all atoms were defined as passive ambiguous
interaction restraints. The knowledge about the catalytic
site in LdtBs, residue C142, was exploited by adding a
distance restraint between the sulfur of C142 and the
carbonyl of the DAP residue in one of the peptides of the
hexameric muropeptide. Best convergence was
achieved when the constraint was applied to the fifth di-
saccharide-tetrapepeptide residue (see Figure S8). More
details about the experimental and calculation procedure
are described in the Supporting Information.
Results
LdtBs tightly binds to peptidoglycan 
 Peptidoglycan is a highly flexible three-dimensional
polymer, and its dynamic nature critically relies on the
aqueous environment. Consequently, only samples con-
taining well-hydrated pellets of peptidoglycan were used
for all experiments that aim at visualizing its interactions
with LdtBs protein, and the impact of this binding on its
dynamics. Upon incubating B. subtilis peptidoglycan sus-
pension with purified LdtBs, the protein concentration in
the supernatant dropped (as evidenced by spectropho-
tometry at 280 nm), indicating that the protein binds to
the peptidoglycan sacculi. Binding of LdtBs to peptidogly-
can sacculi was found to be saturable as the addition of
the protein in excess to 1.5 mg per 10 mg sacculi led to
recovery of excess protein in solution. In order to obtain
atomistic details for this interaction, we transferred the
protein/peptidoglycan sacculi suspension into MAS ro-
tors for analysis by solid-state NMR. 
In a first sample, containing unlabeled peptidoglycan
and U-[13C,15N]-labeled LdtBs, we visualized the state of
the protein through one-dimensional 13C-detected ss-
NMR experiments. Three types of experiments were
used that employ either (i) direct 13C excitation, (ii) cross-
polarization from 1H to 13C prior to 13C-detection or (iii)
scalar-coupling based refocused-INEPT transfer. The
first type of experiment detects all the protein in the sam-
ple, independently of whether the protein is tightly bound
to peptidoglycan or tumbling freely in the surrounding so-
lution. In the second type of experiment, only protein
bound to the (solid-like) peptidoglycan sacculi is de-
tectable, while freely tumbling protein would be unde-
tectable due to averaging through reorientational motion.
The third type of experiment, refocused INEPT, would
lead to detectable signals only in the presence of mo-
tions of large-amplitude, such as overall tumbling.36
These experiments thus provide a qualitative picture of
the protein's dynamic behavior in the presence of pepti-
doglycan. Intense protein signals were observed in the
cross-polarization experiment indicating that LdtBs is
tightly bound to peptidoglycan, adopting the spectro-
scopic properties of a solid-state sample (Figure S1). In
contrast, no signals were detected in a refocused-INEPT
experiment (data not shown), confirming that LdtBs is not
freely tumbling. Taken together, these data reveal that
upon incubation with PG, LdtBs adopts  a solid-like be-
havior, suggesting a strong interaction to the large, solid-
like peptidoglycan sacculi with a rather long residential
time (at least milliseconds or longer). 
 In order to obtain more quantitative insight into the dy-
namics of the protein in this state, we investigated the
amide 1H-15N dipolar couplings of the protein backbone
amides. The dipolar-coupling can be directly related to
the order parameter that describes the motional freedom
of the individual 1H-15N bond vector over time scales
shorter than tens of microseconds. This order parameter,
S, ranges from 0 for complete disorder to 1 in the ab-
sence of any local or global motion. We used a one-di-
mensional version of a REDOR experiment26,27 with 1H
detection, and integrated the whole amide region in this
measurement, to obtain an effective average value. The
bulk amide H-N order parameter is S = 0.82 (Figure S2).
Although this value is clearly lower than what one would
expect for a completely immobilized protein in a crystal
or a precipitate (where S is generally larger than 0.935–38),
it confirms that the protein has adopted the spectro-
scopic properties of a protein in the solid state (in a
freely tumbling protein the dipolar-coupling order param-
eter is zero). The fact that the order parameter is lower
than in typical crystalline samples can be understood
from the fact that the protein is tightly bound to PG,
which itself shows relatively large amplitude motions
(see section below). Residual global flexibility of PG
would necessarily impart some degree of overall motion
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on the interacting LdtBs protein.  We have also measured
bulk 15N R1ρ relaxation rates in a highly deuterated pro-
tein sample at fast magic-angle spinning, as these rates
are sensitive to motions on the time scales of tens of
nanoseconds to microseconds. We find a bulk R1ρ relax-
ation rate of 14 ± 3 s-1, significantly higher than corre-
sponding values in microcrystalline proteins,37–39 where
typical average R1ρ are below 5 s-1. Taken together,
these dynamics measurements show that LdtBs in the
presence of peptidoglycan adopts the behavior of a pro-
tein in the solid state, but that it has a slightly higher flex-
ibility than for proteins embedded in a crystal lattice. This
peculiar protein behavior is presumably due to the flexi-
bility of its binding partner, the peptidoglycan. These re-
sults on the protein prompted us to analyze the dynam-
ics of peptidoglycan in the bound and unbound states.  
Peptidoglycan dynamics in the protein-bound state
In order to obtain insight into the effect of protein bind-
ing on peptidoglycan conformation and dynamics, we
performed 13C-detected experiments on samples con-
taining U-[13C,15N]-labeled peptidoglycan. 
 Figure 1B shows site-resolved measurements of 1H-13C
dipolar couplings for various sites of the peptide and
sugar moieties in peptidoglycan samples with and with-
out LdtBs. Data were acquired using an improved ver-
sion33 of a R1817 recoupling experiment.40 These dipolar
couplings directly can be directly related to the order pa-
rameter of C-H bond motion that reflect the degree of
motional freedom of the bond vectors (ranging from 0 for
full flexibility to 1 for rigid sites). In the absence of pro-
tein, we find order parameters in the order of S = 0.6 for
sugar 1H-13C bonds.1H-13C bonds in the peptide moieties
have values in the 0.2-0.3 range. These values are
clearly much lower than typical order parameters found
in rigid biomolecules, such as microcrystalline, fibrillar or
precipitated protein samples, that show values around
0.9 for 1H-13C and 1H-15N bonds.37,41–43 The significant
flexibility of peptidoglycan, that is reflected by these low
S values, has been reported earlier for hydrated peptido-
glycan.19 In the presence of LdtBs, the order parameters
of the sugar moieties are markedly increased from S ~
0.6 to S ~ 0.8 (Figure 1C), similar to LdtBs's NH order pa-
rameters discussed in the previous section. For the pep-
tide stems of PG, which are more flexible than the sugar
moieties, the presence of protein does not lead to signifi-
cant changes in order parameters. 13C R1 relaxation pa-
rameters, which are sensitive to amplitudes and time
scales of motion, provide a very similar picture to the one
obtained from dipolar couplings (Figure 1D): the pres-
ence of protein leads to prolonged T1 relaxation time
constants of the glycan moieties, while the peptide stems
have shorter T1 relaxation times which are almost identi-
cal with and without protein. These measurements there-
fore unambiguously show that peptidoglycan dynamics
are impacted by the presence of protein. The chemical-
shift changes upon binding are much less pronounced
than the changes in dynamics (Figure S3). This may be
related to the known fact that sugar-protein interactions
generally lead only to relatively small chemical shift per-
turbations.44,45 In addition, given the steric requirements
of a protein binding to peptidoglycan, we must assume
that not all di-saccharide-tetrapeptide subunits are bound
to protein, and our NMR signal is a sum of signals from
free and bound subunits. Within the experimental sensi-
tivity and line width of PG signals, signals from bound
subunits may therefore not be distinguishable from sig-
nal of free subunits. 
Figure 1. The impact of protein binding on peptidoglycan dy-
namics. (A) Chemical structure of peptidoglycan. (B) Mea-
surement of one-bond 1H-13C dipolar couplings in peptido-
glycan, using a windowed R1817 sequence at a MAS fre-
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quency of 7.716 kHz. Dipolar splittings are measured in the
absence (blue) and presence (red) of LdtBs. Dotted lines
show best-fit curves, based on numerical simulations of the
pulse sequence (see Experimental section). (C) 1H-13C dipo-
lar couplings in peptidoglycan without (blue) and with (red)
LdtBs. (D) 13C T1 relaxation time constants without (blue,
data similar to ref. 19) and with (red) LdtBs. 
Atomic model of the complex from 1H-detected ss-
NMR experiments
Having demonstrated that LdtBs binds B. subtilis pepti-
doglycan, we attempted to derive an atomic model for
this complex. In order to identify the binding site on LdtBs
at atomic resolution, we investigated the chemical-shift
changes upon binding by comparing  the NMR spectra of
the LdtB s protein in the absence of PG (i.e. in solution)
and in complex with PG (i.e. in the solid-like sample
state). Care was taken to ensure that the protein, buffer
and temperature conditions were identical in both cases;
solution-state NMR spectra were collected with the pro-
tein sample that was subsequently incubated with PG for
ssNMR. Figure 2A shows the overlay of two-dimensional
proton-detected 1H-15N correlation spectra of U-
[2H,13C,15N] LdtBs collected in solution without peptidogly-
can (blue), and in the solid state, bound to peptidoglycan
(red; collected at a MAS frequency of 39 kHz). Additional
13C-detected NCA and CC spectra are shown in the Sup-
porting Information (Figure S4). The close similarity of
peak positions in the two spectra in Figure 2A immedi-
ately shows that the protein retains the same global fold
upon peptidoglycan interaction. Extraction of precise
site-resolved chemical values was hampered by the sig-
nificant resonance overlap in the solid-state NMR spec-
trum of this 19 kDa protein from such 2D spectra. This
prompted us to collect three-dimensional spectra. The in-
trinsic sensitivity of higher-dimensional spectra is lower,
which is a challenge particularly in the present context,
where the majority of the sample volume is occupied by
peptidoglycan rather than protein. In this context, proton-
detected ssNMR experiments on a deuterated protein
sample turned out to be crucial. The improved sensitivity
of proton-detection under fast MAS allowed the collec-
tion of a 3D (HN)CANHN 1H-13C-15N correlation experi-
ment. Figure 2B shows excerpts from this 3D experi-
ment, overlaid with a corresponding solution-state HNCA
experiment. Figure 2C shows the chemical-shift pertur-
bation (CSP) upon binding, i.e. the combined difference
o f 1H-13Cα-15N chemical shifts, as a function of the
residue number, as derived from these 3D spectra.
Residues with a CSP greater than two standard devia-
tions are represented in red on the free LdtBs structure6 in
Figure 3A. Residues with significant chemical-shift per-
turbation upon the peptidoglycan interaction are located
both in the LysM and catalytic domains.
 
Figure 2. ssNMR characterization of the interaction between
LdtBs and B. subtilis peptidoglycan. A) Comparison of 1H-15N
correlation spectra of [U-2H,13C,15N] LdtBs in solution (blue)
and in the presence of peptidoglycan (red). The latter spec-
trum was collected at a MAS frequency of 39 kHz, using
cross-polarization (CP) transfer steps. B) Representative
excerpts from 3D 1H-13Cα-15N correlation spectra. The peak
labeled with an asterisk (lower right) arises from the correla-
tion to the Cα of the preceding residue 164, which cannot be
observed in the solid state due to pulse sequence design.
Numbers in each panel refer to the 15N chemical shift at
which the displayed 1H-13C planes were extracted. C) Com-
bined chemical shift perturbations (CSP) between free and
bound protein, calculated as the square root of the sum of
the squared absolute chemical shift difference in the 1H,13C,
15N dimensions, weighted by the relative gyromagnetic ra-
tios. Red arrows indicate the residues shown in panel (B).
The red horizontal line displays two standard deviations
over all residues.
Based on these residue-specific interaction data, we
calculated a structural model of the complex using HAD-
DOCK,34 a data-driven docking protocol based on
CNS.35 In this approach, residue-specific CSP data are
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used as ambiguous distance restraints between the re-
spective protein residues and the peptidoglycan during
an energy minimization process performed on the two in-
teracting molecules. For LdtBs, the input structure was the
solution-state NMR-derived structure of the protein.6 For
peptidoglycan, a fragment consisting of six di-saccha-
ride-tetrapeptide subunits was chosen. This fragment is
sufficiently long to cover the whole binding surface of
LdtBs. The use of longer fragments does not lead to sig-
nificant changes, as it leads to (redundant) solutions,
which show the same binding mode, but in which the PG
fragment is translationally shifted. Peptidoglycan is a
three-dimensional polymer, and LdtBs might contact two
separate PG stems. We did not consider this possibility
in the docking process as the absence of structural data
on PG architecture would make a three-body docking
highly ambiguous and our data can be explained with a
single PG fragment.
Figure 3. NMR chemical-shift perturbation (CSP) induced by
the peptidoglycan on LdtBs and result of the HADDOCK cal-
culation. A) CSP are displayed in red on a ribbon represen-
tation of LdtBs. The threshold shown in Figure 2C was used
in this representation. B) Lowest energy structure obtained
for the peptidoglycan-LdtBs complex. The catalytic cysteine
(C142) is shown in yellow. The residues shown in blue are
H122 (left panel) and V47 (right panel), used for mutation
experiments. 
Since peptidoglycan is flexible, a set of ten structures
was generated for the hexamer by an energy-minimiza-
tion process, and docking was performed with all these
conformers as starting structures (Figure S5). The cat-
alytic mechanism of LdtBs involves the formation of a co-
valent link between the C142 of LdtBs and the carbonyl of
DAP in the donor peptide stem.3 For this reason, a dis-
tance restraint between the C142 sulfur and the carbonyl
carbon of one of the DAP residues was used in addition
to the CSP data of Figure 2C for the docking procedure.
As discussed in the Supporting Information, this restraint
improves the convergence of the calculation. However,
the result without the restraint is similar in the sense that
the final solution with the C142-restraint is among the
two best-scoring solutions in a calculation performed
without this restraint (Figure S7). 
The lowest energy model and an ensemble of the five
lowest energy structures of this calculation are presented
in Figures 3B and S8, respectively. In these models, the
LysM domain interacts with each of the six muropeptide
subunits. Additional contacts occur between residues 90-
100, 115-125, and 142 of the catalytic domain and
muropeptides 2 to 5 of the hexamer. Figure S8B shows
a detailed contact map, and Figure S6 illustrates the
change of the PG conformation upon docking. 
Mutants and isolated domains have different bind-
ing affinities than full-length wild-type LdtBs
In order to independently validate this structural model,
we explored how a perturbation of the binding site would
impact the binding. To this end we performed site-di-
rected mutagenesis of LdtBs-residues V47 and H122
which are predicted in our structural model  to be in the
interaction site (shown in blue in Figure 3B). Residue
V47 of the LysM domain interacts with the MurNAc and
peptide moieties of the second disaccharide-peptide
subunit of the hexamer, and H122 is close to the DAP
residue of the fifth disaccharide-peptide. NMR spectra of
the mutant proteins in solution in the absence of peptido-
glycan showed that the V47C and H122A substitutions
did not perturb the overall structure of LdtBs. Moreover,
the substitutions did not prevent binding of LdtBs to pepti-
doglycan since pull-down experiments revealed the ex-
pected decrease in the absorbance at 280 nm in the su-
pernatant upon incubation, similar to wild-type LdtBs. As
with wild-type protein, we performed one-dimensional
13C-detected experiments to follow the  behavior of the
protein. The presence of the two proteins in the PG-pel-
let is evidenced by direct-excitation 13C ssNMR spectra
(Figure S1). However, the 1H-13C cross-polarization
transfer was almost entirely suppressed in both variants,
in strong contrast to the wild-type protein. This cancella-
tion of the 1H-13C dipolar transfer can be explained by dy-
namics, such as a rapid exchange between free and
bound forms of the protein, which averages out the dipo-
lar coupling. Thus, these data show that upon mutation
of V47 or H122, LdtBs interacts less tightly with peptido-
glycan and thereby changes its spectroscopic behavior.
This finding confirms the implication of these residues in
the complex formation.
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Figure 4. Solution-state NMR performed on the individual
LysM and catalytic domains. (A, B) 1D 1H NMR spectra of
the LysM domain recorded in the absence (A, blue) or pres-
ence (B, red) of peptidoglycan. C) Photographs of the re-
spective samples described in A) and B). (D) 1H-15N HSQC
spectra recorded on these two LysM samples. Peaks corre-
sponding to residues with significant chemical shift pertur-
bation (CSP) upon peptidoglycan interaction are high-
lighted. Residue-wise CSP plots are shown in Figure S9.
(E) Position of the backbone sites of residues with signifi-
cant CSP are show as red spheres. The orientation of the
LysM domain is identical to that used in Figure 3A (right
panel). (F, G) 1D 1H NMR spectra of the catalytic domain
recorded in the absence (F, blue) or presence (G, red) of a
peptidoglycan suspension. All 1D spectra resulted from 128
scans except for the spectrum in panel (G) for which 1024
scans were accumulated.  
To evaluate the respective roles of the LysM and cat-
alytic domains in the formation of the LdtBs-peptidolgycan
complex, the two domains were separately produced
and individually incubated with peptidoglycan. A de-
crease in the supernatant absorbance upon incubation
with peptidoglycan showed that both individual domains
still interact with peptidoglycan. Likewise, direct-excita-
tion 13C ssNMR spectra confirmed the presence of the
proteins in the peptidoglycan pellet (Figure S1). How-
ever, similar to the V47C and H122A mutants, the cross-
polarization transfer was found to be very weak, showing
that the interaction of the individual domains is less tight
than the interaction of the full-length protein. 
Interestingly, for the LysM domain, we found efficient
transfer in an INEPT-type experiment under MAS. This
experiment selectively detects either highly flexible parts
of a protein in a solid immobilized state, or proteins tum-
bling freely in solution, but it generally fails to detect pro-
teins in a rigid solid-like state. The observation of LysM
in the INEPT experiment can be rationalized by a rapid
exchange of LysM between a free state in solution and a
peptidoglycan-bound state. This observation prompted
us to perform solution-state NMR experiments on the
peptidoglycan/LysM slurry without MAS. Indeed, LysM is
detected in solution-state NMR in the presence of pepti-
doglycan (Figure 4). 2D 1H-15N solution-state HSQC cor-
relation spectra of LysM in the absence and presence of
peptidoglycan allowed identification of the perturbed
residues upon interaction (Figure 4D). Mapping the cor-
responding CSP data (Panel 4E and Figure S9) identi-
fies the β-sheet structure of LysM as the peptidoglycan
interaction site. This part is also involved in the interac-
tion within the full-length protein. This structural element
also comprises V47 that was shown to be important in
the interaction from the above mutation experiments.
The catalytic domain shows a slightly different behav-
ior. Unlike LysM, the protein is not detected in INEPT ex-
periments (Figure 4G), showing that it is not in fast ex-
change between bound and free states. The cross-polar-
ization (CP) transfer is also inefficient (Figure S1), con-
trasting with the behavior of full-length LdtBs, which sug-
gests that the catalytic domain is not tightly interacting
with peptidoglycan. A possible explanation for this ob-
served behavior is an exchange between different states
(different bound state(s) and possibly also free states) on
a microsecond-to-millisecond time scale. Such a dy-
namic exchange regime would render both INEPT and
CP transfers inefficient. 
Taken together, all the MAS ssNMR and solution-state
NMR spectra show that the individual domains of LdtBs
interact with peptidoglycan and that the LysM binding
sites are similar for the isolated domain and for the full-
length protein. However, the affinities of individual do-
mains are clearly lower than the affinity of full-length
LdtBs. This apparent reliance on both domains for high-
affinity interaction is in agreement with our structural
model, in which both domains make extensive contacts
with peptidoglycan.
It is interesting to note that the interaction site of pepti-
doglycan on the LysM domain of LdtBs differs from the
one observed for other LysM domains in complex with
short soluble oligosaccharides.12,46,47 A comparison of the
structural model proposed here with a crystal structure of
the fungal protein Ecp6 in complex with a short chitin
fragment is shown in Figure S10 in the Supporting Infor-
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mation. This comparison reveals that the binding site of
chitin does not involve LysM's β-sheet, but is rather lo-
cated at the helix adjacent to it (the helix shown on the
left in Figure 4E). In the case of LdtBs studied here, this
part of LysM is not involved in the interaction. The appar-
ent difference between the interaction modes in these
two cases might arise from the different domain organi-
zation of the considered proteins, LdtBs and Ecp6. While
in LdtBs the catalytic domain is close to LysM's β-sheet, it
is on the opposite side of LysM in Ecp6 (Figure S10). As
a consequence, the glycan fragments in the two cases,
peptidoglycan and chitin, respectively, bind in the groove
formed by LysM and the catalytic domain. The orienta-
tion of peptidoglycan we find here enables the peptide
branch to contact the catalytic Cys-142 residue, while
the binding mode observed in the Ecp6 complex would
place the peptidoglycan fragment further away from
LdtBs's catalytic site. Interestingly, the highly conserved
LysM residues (residues G12, D13, T14 and G43 in
LdtBs) are located in between these two binding sites,
such that they can be expected to be involved in com-
plexes formed on either of the two interaction sites. Our
data might thus point to some plasticity of interaction
modes in LysM domains, that seems to depend on the
structural context of LysM in the full-length protein.
Discussion
Peptidoglycan cross-linking by LdtBs and related L,D-
transpeptidases involves two stem peptides that act as
acyl donor and acyl acceptor. In the first step of the
transpeptidation reaction, the catalytic cysteine forms a
covalent thioester with the backbone carbonyl of the third
residue of the acyl donor stem. This reaction can be
blocked by β-lactam antibiotics of the carbapenem class,
which also acylate the catalytic cysteine. The NMR struc-
ture of Ldtfm L,D-transpeptidase covalently bound to the
ertapenem carbapenem has recently been reported.48
Figure 5A shows the superposition of this acylenzyme
structure with the model derived here for the peptidogly-
can-LdtBs complex. Interestingly, the peptide stem of the
fifth disaccharide-peptide subunit occupies the antibiotic
pocket in our HADDOCK model. Thus, this peptide stem
is likely to occupy the position of the acyl donor of the
transpeptidation reaction.
To explore possible locations of the acceptor stem, we
have represented our model in the context of a complete
peptidoglycan structural model generated from a regular
network (Figure 5B). To generate this new model, the
glycosidic chain of the complete peptidoglycan structure
was superimposed with the muropeptides hexamer of
the HADDOCK model. As a result, one of the muropep-
tides interacts through its disaccharide motif and peptide
stem with the LysM and catalytic domains. In this
muropeptide, the backbone carbonyl of the di-
aminopimelic acid in the third position of the stem pep-
tide points towards the catalytic cysteine, playing the role
of the acyl donor. At the same time, the peptide stem at-
tached to a remote glycosidic chain points towards the
catalytic cysteine, mimicking the acyl acceptor. This ten-
tative model proposes the possible localization of the dif-
ferent partners required for the transpeptidation reaction.
It is interesting to revisit the dynamics data shown in
Figure 1 in the light of the proposed model. The binding
of LdtBs to peptidoglycan leads to rigidifaction of the gly-
can part, but much less of the peptide part of peptidogly-
can. In the structural model proposed here, the glycan
parts form tight interactions in the groove formed by the
LysM and catalytic domains of LdtBs (Figure S8B),
whereas the peptide parts are contacting surface
residues outside the groove. It thus appears reasonable
that the rigidification of the glycan strands is more pro-
nounced than the rigidification of the peptides. It is likely
that another mechanism contributes to the rigidification
of peptidoglycan upon protein binding: our dynamics
data do not point to two different sets of dynamic
regimes for protein-bound and free di-saccharide-
tetrapeptide subunits, respectively, but rather suggest a
general stiffening of subunits directly bound to LdtBs well
as non-bound subunits. (Dipolar splittings in Figure 1B
are well fitted with a single order parameter.) A reason
for such a general rigidification might be found in the in-
creased mass and hydrodynamic radius of the network
of protein-loaded peptidoglycan subunits, as compared
to peptidoglycan without bound protein. Through the in-
creased hydrodynamic radius and inertia, protein binding
would lead to a general reduction of mobility, akin to the
reduced motion of beads on a string as compared to the
string without beads.
Conclusions
In summary, we determined here the first atomic-reso-
lution model of a protein (the L,D-transpeptidase LdtBs)
bound to intact peptidoglycan sacculi, based on solid-
state NMR data. The binding mode of peptidoglycan in
this model involves both the LysM and catalytic domains
of LdtBs. The glycosidic chain is located in the groove be-
tween the two domains and in this orientation one of the
peptide stems can reach the catalytic cysteine residue.
The inferred importance of both domains for high-affinity
is supported by NMR experiments performed with iso-
lated domains as well as site-directed mutagenesis. Our
dipolar-coupling data show that peptidoglycan still re-
tains considerable flexibility when protein is bound, al-
though less than in the unbound state. 
Proton-detected ssNMR has been found to be crucial
in order to obtain the structural information reported
here, and this study thus provides another example of
the versatility of 1H-detection in ssNMR.33,49,50 The
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methodology employed here offers a general strategy for
the structural investigation of protein/cell-wall complexes.
It may significantly contribute in designing future antibi-
otics, which do not only target the catalytic site, but also
the complete binding interface on the protein.
Figure 5.  Possible localization of the peptidoglycan peptide
stems into the catalytic pocket. A) Superimposition of our
HADDOCK LdtBs:peptidoglycan-hexamer :model (LdtB s car-
toon structure in red and peptidoglycan in orange sticks)
with the Ldtfm acylenzyme structure (cyan cartoon and sur-
face), with ertapenem (grey mesh). A peptide stem of pepti-
doglycan is localized in the same acyl donor pocket as the
carbapenem antibiotic.  B) Extension of our HADDOCK
LdtBs:peptidoglycan-hexamer model to a complete peptido-
glycan polymer. The hexamer muropeptides of our model
was overlapped with one of the glycosidic chain of the com-
plete peptidoglycan polymer. The peptidoglycan was mod-
eled using a threefold axis for the glycan chains. The pep-
tide conformation was adapted to allow the cross-linking be-
tween adjacent glycan chains.24 Possible acceptor and
donor peptide stems are represented in green and blue, re-
spectively. The catalytic cysteine is shown in yellow.  
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